Longitude Capital Partners IV, LLC Insider Profile
4 Followers
Longitude Capital Partners IV, LLC, Ten Percent Owner at Vera Therapeutics, holds 2.57M shares in Lexeo Therapeutics, Inc. (Ticker: LXEO), holds 5.14M shares in Vera Therapeutics (Ticker: VERA).
Longitude Capital Partners IV, LLC insider profile FAQ
What is the percentage of profitable transactions made by Longitude Capital Partners IV, LLC?
The percentage of profitable transactions made by Longitude Capital Partners IV, LLC is 67%.
What is the average return per transaction made by Longitude Capital Partners IV, LLC?
The average return per transaction made by Longitude Capital Partners IV, LLC is 32.40%.
What stocks does Longitude Capital Partners IV, LLC hold?
Longitude Capital Partners IV, LLC holds: VERA, LXEO stocks.
What was Longitude Capital Partners IV, LLC’s latest transaction?
Longitude Capital Partners IV, LLC latest transaction was an Uninformative Buy of ―.
What was Longitude Capital Partners IV, LLC's most profitable transaction?
Longitude Capital Partners IV, LLC’s most profitable transaction was an Informative Buy of VERA stock on February 8, 2023. The return on the trade was 136.00%.
What is Longitude Capital Partners IV, LLC's role in Vera Therapeutics?
Longitude Capital Partners IV, LLC's role in Vera Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.